Tender Title: Drug and Pharmaceutical Items

Tender Reference Number: GEM/2025/B/6136267

Issuing Authority/Department: Ministry of Defence, Department of Defence

The Ministry of Defence is inviting bids for the procurement of various essential drug and pharmaceutical items under the tender reference number GEM/2025/B/6136267. This procurement process aims to ensure the availability of necessary medications that are pivotal for maintaining health and operational readiness.

Scope of Work and Objectives

The tender includes the supply of pharmaceutical items that play an important role in treatment protocols for various medical conditions. The scope encompasses the following categories:

• GLIMEPRIDE 1 MG and METFORMIN 500 MG TAB
• GLIMEPRIDE 2 MG and METFORMIN 1000 MG SR TAB
• Additional categories including but not limited to Sodium Bicarbonate, Sertraline, Haloperidol, and Hydrochloroquine. The total quantity across all items to be procured is estimated at 182,488 units.

The primary objective is to secure timely and cost-effective supplies that meet stringent quality standards and improve healthcare services within the defence sector.

Eligibility Criteria

Interested bidders must meet the following eligibility criteria to be considered for this tender:

• Be a registered entity with the necessary licenses to conduct business in pharmaceuticals.
• Exhibit a proven track record in the supply of pharmaceutical products.
• Have compliant manufacturing facilities that adhere to all relevant health and safety standards.

Technical Requirements

The technical requirements for bidders include:

• Evidence of adherence to quality standards throughout the production and packaging processes.
• Ability to provide detailed specifications for each pharmaceutical item, including ingredients, dosage forms, and shelf-life.
• Compliance with regulatory requirements set forth by health authorities.

Financial Requirements

Bidders must demonstrate their financial ability to fulfill the contract terms, which includes:

• Submission of a valid Earnest Money Deposit (EMD).
• Financial statements for the last three fiscal years to showcase stability in operations and liquidity.
• A clear pricing structure aligning with the expected quantities listed in the tender.

Document Submission Details

Potential bidders should ensure that they submit all required documents, including:

• Completed bidding forms
• Technical and financial proposals
• Certificates of compliance with quality standards

All documents must be submitted in the formats specified in the tender documentation, and electronic submissions may be preferred for efficiency.

Special Provisions

This tender makes special provisions for Micro, Small, and Medium Enterprises (MSEs) and start-ups, including:

• Relaxed eligibility criteria
• Support for capacity development and training to strengthen their participation in government procurement.

Evaluation Process

The evaluation of proposals will be conducted through a rigorous process that assesses both technical and financial aspects. Key factors include:

• Compliance with the technical specifications and requirements.
• Competitive pricing strategy.
• Timeline for delivery and proven track record of timely supply.

Bidders will be notified of the results upon the conclusion of the evaluation phase.

Delivery Locations

Deliveries are expected to be made to designated locations as specified by the Ministry of Defence. Suppliers must be prepared to meet logistical requirements and timelines to ensure a seamless supply chain.

Contact Information

For further inquiries, bidders may refer to the Ministry of Defence’s official contacts listed in the tender documents. It is encouraged to reach out for question clarifications prior to submission to enhance compliance with the requirements.

In summary, this GEM/2025/B/6136267 tender presents a comprehensive opportunity for qualified suppliers in the pharmaceuticals sector to contribute to the essential health services maintained by the Ministry of Defence. It calls for adherence to quality, compliance with regulatory standards, and a collaborative approach with smaller enterprises to enhance the overall procurement framework.

---